OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment
Juan Zhang, Hong‐Xi Xu, Jiaqian Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 10, pp. 3029-3041
Open Access | Times Cited: 35
Juan Zhang, Hong‐Xi Xu, Jiaqian Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 10, pp. 3029-3041
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Hongying Zhang, Yongliang Liu, Jieya Liu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
Hongying Zhang, Yongliang Liu, Jieya Liu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
Christophe Glorieux, Cinthya Enríquez, Constanza Díaz González, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 70-70
Open Access | Times Cited: 29
Christophe Glorieux, Cinthya Enríquez, Constanza Díaz González, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 70-70
Open Access | Times Cited: 29
Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities
Michelle Yi, L Cisneros, E.J. Cho, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 821-821
Open Access | Times Cited: 18
Michelle Yi, L Cisneros, E.J. Cho, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 821-821
Open Access | Times Cited: 18
5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer
Youming Chen, Zuli Jiang, Chenxing Zhang, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 4, pp. 106793-106793
Open Access | Times Cited: 18
Youming Chen, Zuli Jiang, Chenxing Zhang, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 4, pp. 106793-106793
Open Access | Times Cited: 18
Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway
Xi Yu, Ziqi He, Zhong Wang, et al.
Experimental Cell Research (2024) Vol. 438, Iss. 2, pp. 114053-114053
Open Access | Times Cited: 7
Xi Yu, Ziqi He, Zhong Wang, et al.
Experimental Cell Research (2024) Vol. 438, Iss. 2, pp. 114053-114053
Open Access | Times Cited: 7
Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3
Yuanyuan Wan, Jingsong Cheng, Debiao Gan, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 6
Yuanyuan Wan, Jingsong Cheng, Debiao Gan, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 6
MicroRNA-204-5p Ameliorates Renal Injury via Regulating Keap1/Nrf2 Pathway in Diabetic Kidney Disease
Jiajia Dong, Mengyu Liu, Yawei Bian, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 75-92
Open Access | Times Cited: 5
Jiajia Dong, Mengyu Liu, Yawei Bian, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 75-92
Open Access | Times Cited: 5
The Role of Nrf2 in the Regulation of Mitochondrial Function and Ferroptosis in Pancreatic Cancer
Dinara Baiskhanova, H. Schäfer
Antioxidants (2024) Vol. 13, Iss. 6, pp. 696-696
Open Access | Times Cited: 5
Dinara Baiskhanova, H. Schäfer
Antioxidants (2024) Vol. 13, Iss. 6, pp. 696-696
Open Access | Times Cited: 5
Identification of Penexanthone A as a Novel Chemosensitizer to Induce Ferroptosis by Targeting Nrf2 in Human Colorectal Cancer Cells
Genshi Zhao, Yanying Liu, Xia Wei, et al.
Marine Drugs (2024) Vol. 22, Iss. 8, pp. 357-357
Open Access | Times Cited: 4
Genshi Zhao, Yanying Liu, Xia Wei, et al.
Marine Drugs (2024) Vol. 22, Iss. 8, pp. 357-357
Open Access | Times Cited: 4
In vitro and in silico hybrid approach to unveil triterpenoids from Helicteres hirsuta leaves as potential compounds for inhibiting Nrf2
Hien Minh Nguyen, Nguyen Thien Han Le, Bui Quoc Huy Nguyen, et al.
RSC Advances (2025) Vol. 15, Iss. 3, pp. 1915-1923
Open Access
Hien Minh Nguyen, Nguyen Thien Han Le, Bui Quoc Huy Nguyen, et al.
RSC Advances (2025) Vol. 15, Iss. 3, pp. 1915-1923
Open Access
Dexmedetomidine Inhibits Ferroptosis Through the Akt/Gsk3β/Nrf2 Axis and Alleviates Adriamycin -Induced Cardiotoxicity
Xuefeng Cao, Liang Zhao, Jian Zhou, et al.
(2025)
Closed Access
Xuefeng Cao, Liang Zhao, Jian Zhou, et al.
(2025)
Closed Access
Brusatol inhibits malignant phenotypes and lipid metabolism of osteosarcoma cells by regulating PI3K/AKT and MAPK pathways
Xuhui Yuan, Sun‐Kyoung Yu, Lan Lin, et al.
Phytomedicine (2025) Vol. 139, pp. 156464-156464
Closed Access
Xuhui Yuan, Sun‐Kyoung Yu, Lan Lin, et al.
Phytomedicine (2025) Vol. 139, pp. 156464-156464
Closed Access
Piperlongumine overcomes osimertinib resistance via governing ubiquitination-modulated Sp1 turnover
Ruirui Wang, Qiang Wang, Jinzhuang Liao, et al.
JCI Insight (2025) Vol. 10, Iss. 6
Open Access
Ruirui Wang, Qiang Wang, Jinzhuang Liao, et al.
JCI Insight (2025) Vol. 10, Iss. 6
Open Access
Dexmedetomidine inhibits ferroptosis through the Akt/GSK3β/Nrf2 axis and alleviates adriamycin-induced cardiotoxicity
Xuefeng Cao, Liang Zhao, Jian Zhou, et al.
Life Sciences (2025) Vol. 371, pp. 123609-123609
Closed Access
Xuefeng Cao, Liang Zhao, Jian Zhou, et al.
Life Sciences (2025) Vol. 371, pp. 123609-123609
Closed Access
NRF2 Antioxidant Cellular System as a Therapeutic Target for Enhancing Cancer Radiosensitivity
G. G. Golyshev, K. V. Tikunova, O. A. Zaytsev, et al.
Meditsinskaya Fizika (2025), Iss. 1, pp. 94-109
Closed Access
G. G. Golyshev, K. V. Tikunova, O. A. Zaytsev, et al.
Meditsinskaya Fizika (2025), Iss. 1, pp. 94-109
Closed Access
Self-assembled nanoplatform-mediated co-delivery of brusatol to sensitize sorafenib for hepatocellular carcinoma treatment
Fengrui Liu, Senlin Li, Chengcheng Huang, et al.
RSC Advances (2025) Vol. 15, Iss. 15, pp. 11675-11687
Open Access
Fengrui Liu, Senlin Li, Chengcheng Huang, et al.
RSC Advances (2025) Vol. 15, Iss. 15, pp. 11675-11687
Open Access
Role of Natural Compounds Modulating Heme Catabolic Pathway in Gut, Liver, Cardiovascular, and Brain Diseases
Sri Jayanti, Libor Vı́tek, Camilla Dalla Verde, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 63-63
Open Access | Times Cited: 3
Sri Jayanti, Libor Vı́tek, Camilla Dalla Verde, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 63-63
Open Access | Times Cited: 3
A Descriptive Review of the Antioxidant Effects and Mechanisms of Action of Berberine and Silymarin
Ana María García-Muñoz, Desirée Victoria-Montesinos, Pura Ballester, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4576-4576
Open Access | Times Cited: 3
Ana María García-Muñoz, Desirée Victoria-Montesinos, Pura Ballester, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4576-4576
Open Access | Times Cited: 3
Differences in metabolite profiling by cold atmospheric plasma in normal and cancer cells
A. B. Zinnurova, K. P. Vorobyov, О. В. Бакина, et al.
Journal of Bioenergetics and Biomembranes (2025)
Closed Access
A. B. Zinnurova, K. P. Vorobyov, О. В. Бакина, et al.
Journal of Bioenergetics and Biomembranes (2025)
Closed Access
Unlocking therapeutic potential of trigonelline through molecular docking as a promising approach for treating diverse neurological disorders
Syeda Rehana Zia, Muhammad Wasim, Saara Ahmad
Metabolic Brain Disease (2023) Vol. 38, Iss. 8, pp. 2721-2733
Closed Access | Times Cited: 7
Syeda Rehana Zia, Muhammad Wasim, Saara Ahmad
Metabolic Brain Disease (2023) Vol. 38, Iss. 8, pp. 2721-2733
Closed Access | Times Cited: 7
NRF2 Modulators of Plant Origin and Their Ability to Overcome Multidrug Resistance in Cancers
Piotr Wadowski, Michał Juszczak, Katarzyna Woźniak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11500-11500
Open Access | Times Cited: 2
Piotr Wadowski, Michał Juszczak, Katarzyna Woźniak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11500-11500
Open Access | Times Cited: 2
Protective effects of ginseng and ginsenosides in the development of osteoarthritis (Review)
Jincai Chen, Huang Lin, Xiaofei Liao
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 5
Jincai Chen, Huang Lin, Xiaofei Liao
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 5
Neuroprotective effects of dendrobium endophytes metabolites in SH-SY5Y cells via the Nrf2/Keap1 pathway
Yan Liang, Jia Liu, Lu qi Qin, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28222-e28222
Open Access | Times Cited: 1
Yan Liang, Jia Liu, Lu qi Qin, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28222-e28222
Open Access | Times Cited: 1
In vitro anti-breast cancer study of hybrid cinnamic acid derivatives bearing 2-thiohydantoin moiety
Dalal Nasser Binjawhar, Fawziah A. Al‐Salmi, Maha Al‐Ghamdi, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 16, pp. 1665-1684
Closed Access | Times Cited: 1
Dalal Nasser Binjawhar, Fawziah A. Al‐Salmi, Maha Al‐Ghamdi, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 16, pp. 1665-1684
Closed Access | Times Cited: 1
Unveiling the potential of medicinal herbs as the source for in vitro screening toward the inhibition of Nrf2
Minh Hien Nguyen, Thi Yen Nhi Nguyen, Yi-Siao Chen, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38411-e38411
Open Access | Times Cited: 1
Minh Hien Nguyen, Thi Yen Nhi Nguyen, Yi-Siao Chen, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38411-e38411
Open Access | Times Cited: 1
